Swedish healthtech startup secures €1.5M to combat surgical complications and transform patient recovery
Swedish healthtech startup secures €1.5M to combat surgical complications and transform patient recovery Nurcin Metingil
Stockholm-based health tech startup Encare has recently secured a substantial investment of €1.5 million, signaling a vote of confidence in its mission to transform the landscape of surgical care. This funding round, facilitated by Sciety which is an investment company committed to supporting the growth of life science companies in the Nordics, saw the participation of both existing shareholders and a cohort of new investors eager to support Encare’s innovative approach. The startup’s software-as-a-service (SaaS) solution holds the promise of revolutionizing healthcare providers’ ability to implement best practices in surgical care, ultimately leading to enhanced patient outcomes. With this fresh infusion of capital, the company is poised to continue its growth trajectory and expand its footprint into untapped international markets.
A staggering number of individuals undergo surgical procedures each year, placing their trust in medical professionals to provide effective treatments. However, a persistent challenge lies in the aftermath of these operations, as approximately one in four patients continue to experience complications. Encare seeks to address this issue head-on, asserting that its software can substantially reduce the risk of complications by an impressive 50%. The implications of such a reduction are profound, considering that complications can lead to dire consequences, including loss of life or a significant burden on healthcare expenses.
Founded in 2019, Encare has set itself apart by prioritizing the optimization of the entire patient care process, spanning from the initial diagnosis to comprehensive rehabilitation. By focusing on developing perioperative care protocols and adhering to the highest standards of research, education, and evidence-based practices, Encare has garnered recognition as a trailblazer in the field. Collaborating closely with leading clinical experts, the company has pioneered the ERAS Protocol—a groundbreaking initiative aimed at minimizing post-operative complications and expediting the recovery process. The potential benefits of this approach extend beyond improved patient outcomes, as it also holds the promise of reducing costs for healthcare providers and hospitals while elevating the overall standard of care.
Encare’s recent investment infusion positions the company for continued growth and paves the way for expansion into untapped international markets. With their unwavering commitment to enhancing surgical care and their innovative SaaS solution at the forefront, Encare stands poised to make a lasting impact on the global healthcare landscape.
“Thanks to the continued support from our investors, we can continue our expansion and work towards our mission to positively impact the lives of millions of patients undergoing surgery worldwide. By supporting healthcare providers in implementing best practices in surgical care, Encare can contribute to reducing the number of preventable deaths and complications during surgery,” says Rasmus Waller, CEO of Encare.